section hero-home hero-section
hero-container container
hero image

mobile hero image

hero content
In hATTR amyloidosis...
DISEASE PROGRESSION UNRAVELS THEIR LIVES
The progression of hereditary transthyretin-mediated (hATTR) amyloidosis can pull apart your patients’ futures.1 Identifying the disease early may help patients hold on to their physical
function, independence, and well-being.2-5
Learn to recognize and
diagnose hATTR amyloidosis.
Start Here »section section-boxes mt-20 mb-5
boxes-container container

A multisystem, rapidly progressive disease
The multisystem, rapidly progressive nature of the disease leads to disability and premature death.1,6




Physician directory
Find physicians experienced in managing hATTR amyloidosis who are near your patients.


section section-References grey-bg
References-container container
References
References:
- Coutinho P, Martins da Silva A, Lopes Lima JL, et al. Excerpta Medica. 1980:88-98.
- Conceição I, González-Duarte A, Obici L, et al. J Peripher Nerv Syst. 2016;21(1):5-9.
- Berk J, Lin H, Agarwal S, et al. Poster presented at International Symposium on Amyloidosis; March 26-29, 2018; Kumamoto, Japan.
- Stewart M, Shaffer S, Murphy B, et al. Neurol Ther. 2018;7:349-364.
- Coelho T, Vinik A, Vinik EJ, et al. Muscle Nerve. 2017;55:323-332.
- Ando Y, Coelho T, Berk JL, et al. Orphanet J Rare Dis. 2013;8:31.
- Maurer MS, Elliott P, Comenzo R, et al. Circulation. 2017;135(14):1357-1377.
- Adams D, Suhr OB, Hund E, et al. Curr Opin Neurol. 2016;29(suppl 1):S14-S26.